...
首页> 外文期刊>Colloids and Surfaces, B. Biointerfaces >Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo: Ex vivo permeation and skin irritation studies
【24h】

Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo: Ex vivo permeation and skin irritation studies

机译:局部递送丙酸氯倍他索的微乳液型凝胶的局部递送,可有效治疗白癜风:离体渗透和皮肤刺激性研究

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the present investigation was to evaluate microemulsion as a vehicle for dermal drug delivery and to develop microemulsion based gel (MBC) of clobetasol propionate (CP) for the effective treatment of vitiligo. D-Optimal mixture experimental design was adopted to optimize the amount of oil (X_1), Smix (mixture of surfactant and cosurfactant) (X_2) and water (X_3) in the microemulsion. The formulations were assessed for globule size (nm) (Y_1) and solubility of CP in microemulsion (mg/ml) (Y_2). The microemulsion containing 3% oil, 45% S_(mix) and 50% water was selected as the optimized batch (ME). The globule size and solubility of CP in ME were 18.26 nm and 36.42 mg/ml respectively. Transmission electron microscopy showed that ME globules were spherical in shape. Carbopol 934P was used to convert microemulsion containing drug into gel form without affecting its structure. Ex-vivo permeation studies showed that cumulative amount of CP permeated (Q_n) from ME, MBC and market formulation (MFCP) at 8 h after application were 53.6 ± 2.18, 28.43 ± 0.67 and 37.73 ± 0.77 μg cm~(-2) respectively. MBC showed greater retention of CP in to skin layers than ME and MFCP. Skin irritation studies showed MBC to be significantly less irritating than MFCP. Photomicrographs and scanning electron micrographs of skin sections treated with MBC showed significant changes in the skin structure, which was attributed to the interaction of microemulsion components with skin resulting in permeation enhancement and retention of CP into skin layers. It was concluded that CP loaded gel could be a promising formulation for effective treatment of vitiligo.
机译:本研究的目的是评估微乳作为皮肤药物递送的载体,并开发基于丙酸氯倍他索(CP)的微乳凝胶(MBC),以有效治疗白癜风。采用D-最优混合实验设计,以优化微乳液中油(X_1),混合(表面活性剂和助表面活性剂的混合物)(X_2)和水(X_3)的量。评估制剂的小球尺寸(nm)(Y_1)和CP在微乳液中的溶解度(mg / ml)(Y_2)。选择包含3%的油,45%的S_(混合物)和50%的水的微乳液作为优化批次(ME)。 CP在ME中的球大小和溶解度分别为18.26nm和36.42mg / ml。透射电子显微镜显示ME球为球形。 Carbopol 934P用于在不影响其结构的情况下将含有药物的微乳液转化为凝胶形式。离体渗透研究表明,施用后8小时,ME,MBC和市场配方(MFCP)渗透的CP累积量(Q_n)分别为53.6±2.18、28.43±0.67和37.73±0.77μgcm〜(-2)。 。与ME和MFCP相比,MBC显示出CP在皮肤层中的保留更大。皮肤刺激性研究表明,MBC的刺激性明显低于MFCP。用MBC处理的皮肤切片的显微照片和扫描电子显微照片显示皮肤结构发生了重大变化,这归因于微乳成分与皮肤的相互作用,导致渗透增强和CP进入皮肤层的保留。结论是CP负载凝胶可能是有效治疗白癜风的有前途的制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号